Able View Global is undergoing a fundamental transition from a diversified cross-border brand management platform to a streamlined, functionally focused operator. The fiscal year ended December 2025 marked the first full year of profitability since the 2023 SPAC combination, driven by a $4.8 million disposal gain from shedding the deteriorating Shanghai Jingyue subsidiary. Yet the core continuing operations generated a $2.8 million net loss on 17 percent revenue contraction, reflecting a shrinking brand portfolio and persistent margin pressure in a challenged Chinese consumer environment. The company now manages ten brands versus fifteen two years ago, and revenue concentration in lower-margin distributor channels has risen to 58 percent.
The investment thesis rests on three variables. First, the to-B cross-border conversion of select products from to-C distribution could structurally improve unit economics by reducing variable costs and unlocking mainstream marketplace placement. Management has initiated NMPA compliance for Cure-brand products and expects further transitions. Second, the 1:200 share consolidation approved in March 2026 aims to cure the Nasdaq minimum bid price deficiency before the June 2026 deadline, removing an overhang that has compressed the share price below $1 since October 2025. Third, operating leverage from the streamlined portfolio could stabilize gross margins near 11 percent while selling and marketing expense falls as a percentage of revenue, creating a path to operating breakeven if revenue stabilizes above $100 million.
The binary market implications are clear. Confirmation of the thesis requires evidence that to-B conversion lifts gross margins above 13 percent within four quarters and that the reverse split sustains a bid price above $1.50, signaling institutional re-engagement. A break would be a further brand departure reducing the portfolio below eight names, or failure to regain Nasdaq compliance triggering a delisting process that would eliminate the primary liquidity venue for a Cayman Islands foreign private issuer with limited U.S. retail visibility.